Because alternative dosing schedules haven't been studied as rigorously as FDA-approved regimens, doctors still don't know whether they'll deliver the same results or carry the same risks
We may contact you about our products and services or share information with sponsorship partners, as well as other content that may be of interest to you
The absence of standardized diagnostic criteria contributes to variations in reported prevalence rates
Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy
10.1016/j.bmc.2008.04.067 144 UedaT.UgawaS.IshidaY.ShimadaS
[5] Patients should be aware of important safety considerations, including the risk of pancreatitis (report severe persistent abdominal pain), gallbladder disease, potential worsening of diabetic retinopathy particularly with rapid HbA1c reduction, and increased hypoglycaemia risk when used with insulin or sulfonylureas
